Advancing oncology care through research, innovation, and multidisciplinary collaboration. Passionate about patient-centered solutions, PROs, HRQOL, and evidence-based practices, w a focus on #GUOnc, #GeriOnc & #PallOnc
#ASCO25 FCOI: http://bit.ly/344gKxq
🚨New @ascocancer.bsky.social Guideline Alert! 🌍
Honored to have worked alongside #EnriqueSoto & cols in developing this guideline
Check out the latest recommendations on GA, designed to improve care worldwide
📄Full guideline ascopubs.org/doi/pdf/10.1...
🎙️Don’t miss the accompanying podcast!
Dr. @crisbergerot.bsky.social and Dr. Angela Feraco chair a session examining systems-level care solutions & clinical models that personalize treatment for diverse pt populations, including AYAs and older adults at #ASCOQLTY26. https://bit.ly/4jOLWsE
We are looking forward to #ISOQOL 2026 in Prague!
The @eortc.org#QualityofLife Group will present 16 abstracts (6 oral, 10 poster) showcasing advances in PRO & HRQoL research, paediatric oncology, survivorship and questionnaire development.
🔗 www.eortc.org/blog/2026/10...#GivingVoice2Patients
Geriatric assessment + guided management can reduce treatment toxicity & improve quality of life for older adults with cancer, but uptake remains low, especially in certain settings. For #ASCODailyNews, @crisbergerot.bsky.social & co-authors offer a path forward: https://bit.ly/4jpV1YO#ASCOQLTY26
🔊Join the growing global ASCO PallOnc COP as we kick off the year nurturing old and new connections while gearing up for another successful year.
DM for the zoom meeting link and to join our listserv.
🕒We can't wait to greet you all on Sep 29, 2026 @ 16:00 EST.
Still deciding on SIOG 2026? SIOG members pay a lower registration rate. Joining before you register can bring the cost down and gives you access to the community year-round.
5–7 Nov, Valencia.
https://loom.ly/ITKRCJQ#SIOG2026#GeriOnc#CancerCare
📰 The 2026 @eortc.org#QualityofLife Group (QLG) newsletter has arrived!
Catch up on the latest QLG research and initiatives, including perspectives on the opportunities and challenges of AI in quality of life research.
🔗 qol.eortc.org/newsletters/#GivingVoice2Patients#CancerResearch
Advance the science of oncology. As a JCO Journals reviewer, you can sharpen your own research skills while protecting the quality of cancer research.
Earn CME credits and FASCO™ points. Learn more and become a reviewer today: https://bit.ly/3VvklTa#PeerReviewWeek
Cancer's impact knows no borders. Conquer Cancer has supported researchers in over 102 countries—representing about 52% of countries worldwide. Learn more at conquer.org.
Thank you ASCO member Dr. @fumikochino.bsky.social for speaking on the importance of federal cancer research funding! #ASCOAdvocacy continues to urge Congress to pass a full, bipartisan FY27 bill to provide the strongest possible investments in medical research.
What’s the optimal follow-up visit schedule for patients with #breastcancer? The latest ASCO guideline update recommends a risk-based approach. See the highlights in #ASCODailyNews: https://bit.ly/4xwJoUh
The add-on sessions at SIOG 2026 are how the conference gets off to a strong start. Five sessions on 5 November, pre-registration required and several run in parallel. Early bird open until 8 September. https://loom.ly/LBPOUSE#SIOG2026#GeriOnc
What does bringing geriatric assessment into routine practice actually look like? This #SIOGwebinar on 5 August at 15:00 CEST has two clinicians sharing their experiences. Free, open to all. Register: https://loom.ly/svYTJsA#GeriatricOncology#GeriOnc
We are live today at 15:00 CEST. Geriatric assessment in routine cancer care. Free to join. Register: https://loom.ly/svYTJsA#GeriatricOncology#GeriOnc
ASCO is pleased to name Thomas E. Stinchcombe, MD, FASCO from @dukecancer.bsky.social as the new Editor-in-Chief of JCO, beginning January 2027.
Dr. Stinchcombe’s expertise will drive innovation, faster publication timelines, and expanded global reach for high-impact cancer research.
⏳ TIME IS RUNNING OUT!
The IPOS Delphi Study on global psycho-oncology competencies closes August 21. Don't let international clinical standards be set without your expertise!
Shape the future here: hku.au1.qualtrics.com/jfe/form/SV_...
Can treatment for intermediate-risk #Rhabdomyosarcoma be refined to improve local control while reducing long-term toxicity?
Read the article: https://bit.ly/4q7tOvp
There’s no wrong way to experience #KCRS26, just the way that works best for you.
However you attend, you'll be part of the community working to accelerate progress in #KidneyCancer research.
Register today: https://bit.ly/KCRS26Registration#AcceleratingCures
Excited to be selected as a social media ambassador for #MASCC26!
Looking forward to sharing the latest research in supportive care alongside my amazing colleagues from across the globe!
Follow along!
@cancercaremascc.bsky.social
👥 Registration opens at 3pm today for @cancercaremascc.bsky.social#MASCC26!
🩺 Can’t wait to see and learn alongside my colleagues & present on survivorship with @michael-jefford.bsky.social & #DrLarissaNekhlyudov!
🇦🇺 See you soon!
Our new position statement outlines ways to expand eligibility, increase funding & expand community access for pediatric oncology clinical trials.
Learn more: https://bit.ly/4v1q7J7#ASCOAdvocacy
Less than 2 weeks to go!
Webinar: High Risk of Fear of Cancer Recurrence
June 15, 2026, 1 to 2 p.m. EDT
Live Webcast
FEATURING:
1. Lauren Rudy
2. Prof. Dr. Marije van der Lee
3. Dr. Sophie Lebel
For more information and to register ipos-society.org/event-6683185
🎙 It's the final daily episode of #ASCO26! Dr. Monty Pal of @cityofhope.bsky.social provides his Top Takeaways on key Day 5 abstracts, available now on the #ASCODailyNews Podcast: https://bit.ly/3Rv9wPj
Heading home from #ASCO26 today! Put two dates for @ascocancer.bsky.social Quality Care Symposium on your calendar:
🚨Abstracts are due in 2 weeks 6/16/2026
📆 #ASCOQLTY26 is Friday-Saturday 10/16-17/2026
See you in Boston!
www.asco.org/quality
The final study presented at #ASCO26 Plenary: RASolute-302 results show daraxonrasib meeting all primary and key secondary endpoints, demonstrating significant and clinically meaningful improvements in OS, PFS, and ORR in metastatic #PDAC: https://bit.ly/49r62n1#ASCODailyNews
Join us for our **Live Meeting** @ascocancer.bsky.social on Saturday May 30th 4:30-6p CST Room E253cd #ASCO26@realbowtiedoc.bsky.social@darcyburbage.bsky.social@crisbergerot.bsky.social@tingtingzhang.bsky.social@fionnualacrowley.bsky.social@ericroeland.bsky.social
IKCC and the Global Cancer Coalitions Network are convening at IARC-WHO in Lyon, France for the GCCN Annual Meeting 2026. Representatives from global patient association networks are collaborating to address the challenges faced by patient organisations and to establish shared goals for 2030.
Webinar: Expert Session FORWard Interest Group Featuring Ben Smith (Australia) — May 18, 2026
Dr. Ben Smith has a particular interest in fear of cancer recurrence, digital health interventions and underserved populations impacted by cancer.
Read more ipos-society.org/event-6673842
World Kidney Cancer Day is just around the corner—less than two months to go! 💙
Mark your calendars for 18 June 2026, and join us as we shine a light on this year’s important theme: Kidney Cancer and Emotional Wellbeing. Find out more: ikcc.org/world-kidney...#WorldKidneyCancerDay#WKCD
Managing advanced RCC after adjuvant immunotherapy
In this roundtable discussion, experts explore treatment strategies for patients with disease progression following adjuvant pembrolizumab.
🎥 : https://ow.ly/o2FW50YLe9Q
Abstract titles for #ASCO26 are now available! Get a first look at the science that will be presented and be a part of the conversation.
Browse the titles and start planning your experience: https://bit.ly/4cecv6w
If you haven’t yet registered, early reg ends tomorrow!
Updated NCCN guidance recommends starting breast cancer screening at age 35 for women identified as high-risk through AI models or other validated risk assessment tools.
➡️ This signals a broader move toward data-driven, individualized screening pathways.
https://ow.ly/WFjY50YLecm
Elevate the quality, safety & efficiency of cancer care delivery—submit your research to #ASCOQLTY26. By presenting findings, you’re shaping a vibrant community of professionals dedicated to advancing patient care.
Prepare your submission: https://bit.ly/4cF0WUW
Cancer risk isn’t just about age.
A study of 450K people shows lifetime risk varies by up to 2x between individuals. Age-only screening misses high-risk patients and overtests low-risk ones.
The future? Personalized, risk-based screening. Read the full article: https://bit.ly/4dYankA
We are so excited for our April meeting in collaboration with
@mycarg.bsky.social and #GeriOncCoP with guest speaker #DrDale
Please DM for the link or to be added to the mailing list.
@crisbergerot.bsky.social@realbowtiedoc.bsky.social@tingtingzhang.bsky.social@fionnualacrowley.bsky.social
🎉Thank you to our dedicated volunteers! Together we connected with lawmakers & advocated for cancer care and research priorities during the 2026 #ASCOAdvocacySummit and Week of Action.
Learn more: https://bit.ly/4vOEbX8